Schumacher Melanie, Nicholson Pamela, Stoffel Michael H, Chandran Suchismita, D'Mello Adonis, Ma Li, Vashee Sanjay, Jores Joerg, Labroussaa Fabien
Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland.
Division of Veterinary Anatomy, University of Bern, Bern, Switzerland.
Front Microbiol. 2019 Jun 19;10:1344. doi: 10.3389/fmicb.2019.01344. eCollection 2019.
Members of the " cluster" are important animal pathogens causing diseases including contagious bovine pleuropneumonia and contagious caprine pleuropneumonia, which are of utmost importance in Africa or Asia. Even if all existing vaccines have shortcomings, vaccination of herds is still considered the best way to fight mycoplasma diseases, especially with the recent and dramatic increase of antimicrobial resistance observed in many mycoplasma species. A new generation of vaccines will benefit from a better understanding of the pathogenesis of mycoplasmas, which is very patchy up to now. In particular, surface-exposed virulence traits are likely to induce a protective immune response when formulated in a vaccine. The candidate virulence factor L-α-glycerophosphate oxidase (GlpO), shared by many mycoplasmas including , was suggested to be a surface-exposed enzyme in subsp. responsible for the production of hydrogen peroxide directly into the host cells. We produced a isogenic mutant GM12::YCpMmyc1.1- using in-yeast synthetic genomics tools including the tandem-repeat endonuclease cleavage (TREC) technique followed by the back-transplantation of the engineered genome into a mycoplasma recipient cell. GlpO localization in the mutant and its parental strain was assessed using scanning electron microscopy (SEM). We obtained conflicting results and this led us to re-evaluate the localization of GlpO using a combination of and techniques, such as Triton X-114 fractionation or tryptic shaving followed by immunoblotting. Our results unambiguously support the finding that GlpO is a cytoplasmic protein throughout the " cluster." Thus, the use of GlpO as a candidate vaccine antigen is unlikely to induce a protective immune response.
该“菌群”的成员是重要的动物病原体,可引发包括传染性牛胸膜肺炎和传染性山羊胸膜肺炎在内的疾病,这些疾病在非洲或亚洲极为重要。即便所有现有疫苗都存在缺陷,但对畜群进行疫苗接种仍被视为对抗支原体疾病的最佳方式,尤其是鉴于最近在许多支原体物种中观察到的抗菌素耐药性急剧增加。新一代疫苗将受益于对支原体发病机制的更深入了解,而目前这方面的了解还很不全面。特别是,表面暴露的毒力特征在制成疫苗时可能会诱导保护性免疫反应。包括[具体支原体名称未给出]在内的许多支原体共有的候选毒力因子L-α-甘油磷酸氧化酶(GlpO),在[具体亚种名称未给出]亚种中被认为是一种表面暴露的酶,负责直接向宿主细胞中产生活性氧。我们使用酵母合成基因组学工具,包括串联重复内切酶切割(TREC)技术,随后将工程化基因组回移植到支原体受体细胞中,构建了一个GlpO同基因突变体GM12::YCpMmyc1.1-。使用扫描电子显微镜(SEM)评估突变体及其亲本菌株中GlpO的定位。我们得到了相互矛盾的结果,这促使我们结合[具体技术名称未给出]和[具体技术名称未给出]技术,如Triton X-114分级分离或胰蛋白酶刮削后进行免疫印迹,重新评估GlpO的定位。我们的[具体结果未明确给出]结果明确支持以下发现:在整个“菌群”中,GlpO是一种胞质蛋白。因此,将GlpO用作候选疫苗抗原不太可能诱导保护性免疫反应。